Clear lens extraction as the first line treatment of primary angle closure/primary angle closure glaucoma
Perspective

Clear lens extraction as the first line treatment of primary angle closure/primary angle closure glaucoma

Kyung Rim Sung1, Jae Yeun Lee2, Joon Mo Kim2

1Department of Ophthalmology, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea; 2Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Correspondence to: Joon Mo Kim. Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. Email: kjoonmo1@gmail.com.

Comment on: Azuara-Blanco A, Burr J, Ramsay C, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet 2016;388:1389-97.


Abstract: Angle closure glaucoma (ACG) is one of the major causes of blindness. Angle closure occurs from the obstruction of the trabecular meshwork by the peripheral iris, which results in increased intraocular pressure (IOP) through impaired aqueous flow. Considering pupillary block by crystalline lens is the most frequent mechanism, lens extraction is regarded as an effective therapy. Recently, to validate the effect of lens extraction, the EAGLE study was reported. In this study, subjects were 50 years or older, did not have cataracts, and had newly diagnosed primary angle closure (PAC) with intraocular pressure 30 mmHg or greater or primary angle-closure glaucoma (PACG), and were divided into clear-lens extraction group and standard care group (laser peripheral iridotomy and topical glaucoma medication). This study suggested that clear-lens extraction showed greater efficacy and was more cost-effective than laser peripheral iridotomy. Initial clear lens extraction showed better clinical course and patient-reported outcomes. This study provided evidence to support clear lens extraction as the first line treatment for PAC with high IOP or PACG patients.

Keywords: EAGLE; angle closure; glaucoma


Received: 22 December 2016; Accepted: 23 January 2017; Published: 31 January 2017.

doi: 10.21037/aes.2017.01.06


Angle closure glaucoma (ACG) is one of the major causes of blindness, especially in Asian populations. Angle closure occurs from the obstruction of the trabecular meshwork by the peripheral iris, which results in impaired aqueous flow. This leads to intraocular pressure (IOP) elevation and eventually glaucomatous optic neuropathy (1,2). Considering that acute sudden IOP elevation is a vision-threatening condition, timely treatment is of crucial importance (1,2). For appropriate and effective treatment, clinicians need to diagnose the principle mechanism of ACG in each patient. Several mechanisms are known to play a role in the pathogenesis of ACG. Needless to say, pupillary block is the most frequent mechanism of ACG. It is initiated by the relative resistance of aqueous flow from the posterior chamber to the anterior chamber via the pupil, which builds up pressure in the posterior chamber and makes the iris bow out, finally prompting iridotrabecular contact. An increase in the lens vault can directly narrow the anterior chamber angle; furthermore, it can aggravate iridolenticular contact, which eventually worsens pupillary block. Lee et al. (3) suggested that the lens vault was the important factor for the mechanism of acute angle closure. In that study, a greater lens vault was the most prominent feature in affected eyes compared to fellow eyes within the same patient in acute primary angle closure (PAC). Usually, laser iridotomy with/without medication which can relieve pupillary block is the first line therapy in ACG. However, IOP cannot be normalized in eyes with greater lens vaults, despite successful laser iridotomy. Further, eyes that underwent laser iridotomy showed a gradual increment of the lens vault, which may lead to re-closure of the anterior chamber angle after laser iridotomy (4).

Hence, lens extraction is regarded as an effective and essential therapy, considering various mechanisms. Lam et al. (5) suggested that both early phacoemulsification and laser iridotomy were successful but showed lower IOP, fewer medications, and deeper angles following lens removal when compared to laser iridotomy. Dada et al. (6) reported that clear lens extraction induced a significant reduction in IOP with a widening of the anterior chamber angle, and a reduced need for ocular hypotensive medications in PAC eyes. Compared to trabeculectomy, Man et al. (7) suggested that clear lens extraction led to a significant reduction in synechial angle closure with a deepening of the anterior chamber angle in primary angle closure glaucoma (PACG) eyes without cataracts. Senthil et al. (8) also suggested that cataract surgery and combined surgery resulted in similar IOP control in phacomorphic glaucoma patients. Therefore, there have been some publications which advocated lens extraction as a definitive treatment for ACG. However, considering the risks of surgery and benefits of phakic status, the usefulness of clear lens extraction in PACG remains controversial.

Recently, a noteworthy study reported on the effectiveness of early lens extraction for the treatment of PACG with a randomised controlled trial (9). In this prospective multicenter study (30 hospitals in 5 countries), patients were assigned with a web-based randomized application to undergo clear-lens extraction or receive standard care with laser peripheral iridotomy and topical medical treatment. This study included patients who were aged 50 years or older without cataracts who had newly diagnosed PAC with an IOP 30 mmHg or greater or PACG. PAC was defined as iridotrabecular contact of at least 180°, either appositional or synechial, and PACG was defined when glaucomatous optic neuropathy was present. The primary endpoints were patient-reported health status, IOP, and incremental cost-effectiveness ratio per quality-adjusted life-year gained 36 months after treatment. One hundred fifty five PAC patients and 263 primary angle-closure glaucoma patients were enrolled. Among them, 208 were assigned to clear-lens extraction and 211 to standard care. The quality of life score was 0.052 higher and the mean IOP was 1.18 mmHg lower after clear-lens extraction than after standard care. Only 21% of participants in the clear-lens extraction group received any further treatment to control IOP (61% received at least one glaucoma drop in the LI group). Further need for glaucoma surgery was reduced in the initial clear-lens extraction group compared to the standard care group (1 vs. 24 operations). Patients undergoing clear-lens extraction became emmetropic (0.08±0.95 diopters), whereas the laser iridotomy group was more hyperopic (0.92±2.8 diopters). The uncorrected distance and near visual acuity were better in the clear-lens extraction group. Initial cost is definitely high in the clear lens extraction group, but cost effectiveness improves when the savings associated with reduced need for subsequent procedures and medications are taken into account. This study suggested that clear-lens extraction showed greater efficacy and was more cost-effective than laser peripheral iridotomy, and should be considered as an option for first-line treatment. Most previous studies which explored the significance of lens extraction in PAC were for PAC patients who had sick lenses, such as cataracts or abnormalities in lens position. The EAGLE study was a multicenter international randomized controlled trial, and the result showed that initial clear lens extraction for PAC and PACG was better in terms of clinical course and patient-reported outcomes. Therefore, these approaches are likely to be effective for a public support health care system. Laser iridotomy is known to widen the anterior chamber angle, but the effect was not permanent. Jiang et al. reported that increased angle width after laser iridotomy remained stable for 6 months, and then decreased significantly by 18 months (10). While complications of surgery should be considered even though they are rare, this study provided evidence to support clear lens extraction as the first line treatment for PAC with high IOP or PACG patients.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was commissioned and reviewed by Section Editor Yi Sun, MD (Department of Ophthalmology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China).

Conflicts of Interest: The authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/aes.2017.01.06). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Trikha S, Perera SA, Husain R, et al. The role of lens extraction in the current management of primary angle-closure glaucoma. Curr Opin Ophthalmol 2015;26:128-34. [Crossref] [PubMed]
  2. Baig N, Kam KW, Tham CC. Managing Primary Angle Closure Glaucoma - The Role of Lens Extraction in this Era. Open Ophthalmol J 2016;10:86-93. [Crossref] [PubMed]
  3. Lee JR, Sung KR, Han S. Comparison of anterior segment parameters between the acute primary angle closure eye and the fellow eye. Invest Ophthalmol Vis Sci 2014;55:3646-50. [Crossref] [PubMed]
  4. Lee KS, Sung KR, Shon K, et al. Longitudinal changes in anterior segment parameters after laser peripheral iridotomy assessed by anterior segment optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54:3166-70. [Crossref] [PubMed]
  5. Lam DS, Leung DY, Tham CC, et al. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. Ophthalmology 2008;115:1134-40. [Crossref] [PubMed]
  6. Dada T, Rathi A, Angmo D, et al. Clinical outcomes of clear lens extraction in eyes with primary angle closure. J Cataract Refract Surg 2015;41:1470-7. [Crossref] [PubMed]
  7. Man X, Chan NC, Baig N, et al. Anatomical effects of clear lens extraction by phacoemulsification versus trabeculectomy on anterior chamber drainage angle in primary angle-closure glaucoma (PACG) patients. Graefes Arch Clin Exp Ophthalmol 2015;253:773-8. [Crossref] [PubMed]
  8. Senthil S, Chinta S, Rao HL, et al. Comparison of Cataract Surgery Alone Versus Cataract Surgery Combined With Trabeculectomy in the Management of Phacomorphic Glaucoma. J Glaucoma 2016;25:e209-13. [Crossref] [PubMed]
  9. Azuara-Blanco A, Burr J, Ramsay C, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet 2016;388:1389-97. [Crossref] [PubMed]
  10. Jiang Y, Chang DS, Zhu H, et al. Longitudinal changes of angle configuration in primary angle-closure suspects: the Zhongshan Angle-Closure Prevention Trial. Ophthalmology 2014;121:1699-705. [Crossref] [PubMed]
doi: 10.21037/aes.2017.01.06
Cite this article as: Sung KR, Lee JY, Kim JM. Clear lens extraction as the first line treatment of primary angle closure/primary angle closure glaucoma. Ann Eye Sci 2017;2:6.

Download Citation